CA3185751A1 - Combination porcine vaccine - Google Patents

Info

Publication number

CA3185751A1

CA3185751A1 CA3185751A CA3185751A CA3185751A1 CA 3185751 A1 CA3185751 A1 CA 3185751A1 CA 3185751 A CA3185751 A CA 3185751A CA 3185751 A CA3185751 A CA 3185751A CA 3185751 A1 CA3185751 A1 CA 3185751A1

Authority

CA

Canada

Prior art keywords

vaccine

antigen

pcv

animal

prrsv

Prior art date

2020-07-24

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 229960005486 vaccine Drugs 0.000 title claims abstract description 655
• 241001148567 Lawsonia intracellularis Species 0.000 claims abstract description 292
• 102000036639 antigens Human genes 0.000 claims abstract description 248
• 108091007433 antigens Proteins 0.000 claims abstract description 248
• 239000000427 antigen Substances 0.000 claims abstract description 244
• 241000202347 Porcine circovirus Species 0.000 claims abstract description 219
• 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 claims abstract description 171
• 244000052769 pathogen Species 0.000 claims abstract description 35
• 230000001717 pathogenic effect Effects 0.000 claims abstract description 34
• 241000204045 Mycoplasma hyopneumoniae Species 0.000 claims abstract description 10
• 241001465754 Metazoa Species 0.000 claims description 240
• 238000000034 method Methods 0.000 claims description 177
• 230000028993 immune response Effects 0.000 claims description 154
• 230000001681 protective effect Effects 0.000 claims description 111
• 208000009326 ileitis Diseases 0.000 claims description 87
• 230000003902 lesion Effects 0.000 claims description 79
• 239000002671 adjuvant Substances 0.000 claims description 73
• 241000700605 Viruses Species 0.000 claims description 65
• 239000000203 mixture Substances 0.000 claims description 64
• 241000894006 Bacteria Species 0.000 claims description 57
• 230000002238 attenuated effect Effects 0.000 claims description 55
• 241001469654 Lawsonia <weevil> Species 0.000 claims description 47
• 241000701447 unidentified baculovirus Species 0.000 claims description 44
• 230000002550 fecal effect Effects 0.000 claims description 41
• 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims description 40
• 229920002125 Sokalan® Polymers 0.000 claims description 36
• 208000015181 infectious disease Diseases 0.000 claims description 35
• 230000003115 biocidal effect Effects 0.000 claims description 31
• 239000002552 dosage form Substances 0.000 claims description 31
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
• 229920001184 polypeptide Polymers 0.000 claims description 30
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 30
• 210000003405 ileum Anatomy 0.000 claims description 28
• 238000002360 preparation method Methods 0.000 claims description 27
• 201000010099 disease Diseases 0.000 claims description 26
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 26
• 230000001939 inductive effect Effects 0.000 claims description 23
• 239000002245 particle Substances 0.000 claims description 23
• 230000003053 immunization Effects 0.000 claims description 22
• 101100382437 Porcine circovirus 2 Cap gene Proteins 0.000 claims description 20
• 235000021052 average daily weight gain Nutrition 0.000 claims description 20
• 239000000047 product Substances 0.000 claims description 20
• 241000894007 species Species 0.000 claims description 17
• 230000003612 virological effect Effects 0.000 claims description 17
• 230000037396 body weight Effects 0.000 claims description 16
• 101150009852 ORF2 gene Proteins 0.000 claims description 15
• 150000002148 esters Chemical class 0.000 claims description 15
• XDOFQFKRPWOURC-UHFFFAOYSA-N iso-octadecanoic acid Natural products CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 15
• 101150040063 orf gene Proteins 0.000 claims description 15
• SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 14
• CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 14
• -1 isostearic acid ester Chemical class 0.000 claims description 14
• 229920000642 polymer Polymers 0.000 claims description 14
• NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 13
• 239000000839 emulsion Substances 0.000 claims description 12
• 230000003903 intestinal lesions Effects 0.000 claims description 12
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
• 230000001965 increasing effect Effects 0.000 claims description 11
• 239000007764 o/w emulsion Substances 0.000 claims description 11
• 239000006228 supernatant Substances 0.000 claims description 11
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
• VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 claims description 10
• 229960001631 carbomer Drugs 0.000 claims description 10
• 125000004432 carbon atom Chemical group C* 0.000 claims description 10
• GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 10
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
• PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 10
• 150000001875 compounds Chemical class 0.000 claims description 9
• 150000005846 sugar alcohols Chemical class 0.000 claims description 9
• 238000007910 systemic administration Methods 0.000 claims description 9
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
• 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
• 239000000194 fatty acid Substances 0.000 claims description 8
• 229930195729 fatty acid Natural products 0.000 claims description 8
• 150000004665 fatty acids Chemical class 0.000 claims description 7
• 239000003921 oil Substances 0.000 claims description 6
• 238000006384 oligomerization reaction Methods 0.000 claims description 6
• 229930182490 saponin Natural products 0.000 claims description 6
• 150000007949 saponins Chemical class 0.000 claims description 6
• JNYAEWCLZODPBN-KVTDHHQDSA-N (2r,3r,4r)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@@H](O)[C@H]1O JNYAEWCLZODPBN-KVTDHHQDSA-N 0.000 claims description 5
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 5
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 5
• ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 claims description 5
• KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 claims description 5
• UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 claims description 5
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 5
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 5
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 5
• 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims description 5
• 102000009016 Cholera Toxin Human genes 0.000 claims description 5
• 108010049048 Cholera Toxin Proteins 0.000 claims description 5
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 5
• 101710146739 Enterotoxin Proteins 0.000 claims description 5
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 5
• 239000005662 Paraffin oil Substances 0.000 claims description 5
• 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 5
• 108010073443 Ribi adjuvant Proteins 0.000 claims description 5
• NKVLDFAVEWLOCX-GUSKIFEASA-N [(2s,3r,4s,5r,6r)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxy-6-methyloxan-2-yl] (4ar,5r,6as,6br,9s,10s,12ar)-10-[(2r,3r,4s, Chemical compound O([C@H]1[C@H](O)CO[C@H]([C@@H]1O)O[C@H]1[C@H](C)O[C@H]([C@@H]([C@@H]1O)O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@H]1OC(=O)[C@]12CCC(C)(C)CC1C1=CCC3[C@@]([C@@]1(C[C@H]2O)C)(C)CCC1[C@]3(C)CC[C@@H]([C@@]1(C)C=O)O[C@@H]1O[C@@H]([C@H]([C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)CO2)O)[C@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O)C(=O)NCCCCCCCCCCCC)[C@@H]1OC[C@](O)(CO)[C@H]1O NKVLDFAVEWLOCX-GUSKIFEASA-N 0.000 claims description 5
• UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 claims description 5
• 239000002253 acid Substances 0.000 claims description 5
• 150000001336 alkenes Chemical class 0.000 claims description 5
• 125000003342 alkenyl group Chemical group 0.000 claims description 5
• 125000000217 alkyl group Chemical group 0.000 claims description 5
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 5
• ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims description 5
• WXNRAKRZUCLRBP-UHFFFAOYSA-N avridine Chemical compound CCCCCCCCCCCCCCCCCCN(CCCN(CCO)CCO)CCCCCCCCCCCCCCCCCC WXNRAKRZUCLRBP-UHFFFAOYSA-N 0.000 claims description 5
• 229950010555 avridine Drugs 0.000 claims description 5
• 229920001400 block copolymer Polymers 0.000 claims description 5
• 229920001577 copolymer Polymers 0.000 claims description 5
• 239000000147 enterotoxin Substances 0.000 claims description 5
• 231100000655 enterotoxin Toxicity 0.000 claims description 5
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 5
• 229940093471 ethyl oleate Drugs 0.000 claims description 5
• 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 5
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 5
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 5
• 229940057995 liquid paraffin Drugs 0.000 claims description 5
• FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 5
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
• 229940035032 monophosphoryl lipid a Drugs 0.000 claims description 5
• BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims description 5
• JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 5
• AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 claims description 5
• 239000002736 nonionic surfactant Substances 0.000 claims description 5
• 229940049964 oleate Drugs 0.000 claims description 5
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 5
• 150000002888 oleic acid derivatives Chemical class 0.000 claims description 5
• 239000010773 plant oil Substances 0.000 claims description 5
• 229920001983 poloxamer Polymers 0.000 claims description 5
• 229920000058 polyacrylate Polymers 0.000 claims description 5
• 229920000223 polyglycerol Polymers 0.000 claims description 5
• 229940010310 propylene glycol dioleate Drugs 0.000 claims description 5
• 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 5
• WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 claims description 5
• FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 claims description 5
• 229940032094 squalane Drugs 0.000 claims description 5
• 229940038774 squalene oil Drugs 0.000 claims description 5
• 125000001424 substituent group Chemical group 0.000 claims description 5
• 235000000346 sugar Nutrition 0.000 claims description 5
• 150000003505 terpenes Chemical class 0.000 claims description 5
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 5
• 229920002554 vinyl polymer Polymers 0.000 claims description 5
• 239000007762 w/o emulsion Substances 0.000 claims description 5
• JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 claims description 4
• 229960003656 ricinoleic acid Drugs 0.000 claims description 4
• 241000588724 Escherichia coli Species 0.000 claims description 3
• 210000004027 cell Anatomy 0.000 description 137
• 241000282887 Suidae Species 0.000 description 64
• 238000011282 treatment Methods 0.000 description 61
• 238000002255 vaccination Methods 0.000 description 59
• 241000282898 Sus scrofa Species 0.000 description 56
• 108090000623 proteins and genes Proteins 0.000 description 42
• 241001673669 Porcine circovirus 2 Species 0.000 description 40
• 230000002163 immunogen Effects 0.000 description 37
• 102000004169 proteins and genes Human genes 0.000 description 31
• 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 28
• 101710130262 Probable Vpr-like protein Proteins 0.000 description 28
• UURAUHCOJAIIRQ-QGLSALSOSA-N tiamulin Chemical compound CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 UURAUHCOJAIIRQ-QGLSALSOSA-N 0.000 description 27
• 239000004099 Chlortetracycline Substances 0.000 description 26
• CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 26
• 229960004475 chlortetracycline Drugs 0.000 description 26
• CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 26
• 235000019365 chlortetracycline Nutrition 0.000 description 26
• 239000002773 nucleotide Substances 0.000 description 26
• 125000003729 nucleotide group Chemical group 0.000 description 26
• 238000007918 intramuscular administration Methods 0.000 description 22
• 239000004599 antimicrobial Substances 0.000 description 21
• 210000004369 blood Anatomy 0.000 description 21
• 239000008280 blood Substances 0.000 description 21
• 108020004414 DNA Proteins 0.000 description 19
• 238000003364 immunohistochemistry Methods 0.000 description 19
• 239000007924 injection Substances 0.000 description 19
• 238000002347 injection Methods 0.000 description 19
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 18
• LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 18
• 239000013642 negative control Substances 0.000 description 18
• 239000013598 vector Substances 0.000 description 18
• 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 17
• 101710113540 ORF2 protein Proteins 0.000 description 17
• 101710090523 Putative movement protein Proteins 0.000 description 17
• 238000004519 manufacturing process Methods 0.000 description 17
• 230000012010 growth Effects 0.000 description 16
• 238000012360 testing method Methods 0.000 description 16
• 229960004885 tiamulin Drugs 0.000 description 16
• 230000000845 anti-microbial effect Effects 0.000 description 15
• 241000928435 Porcine circovirus 1 Species 0.000 description 14
• 239000003085 diluting agent Substances 0.000 description 14
• 230000009467 reduction Effects 0.000 description 14
• 239000000725 suspension Substances 0.000 description 14
• 210000001519 tissue Anatomy 0.000 description 14
• 241000238631 Hexapoda Species 0.000 description 12
• 238000011887 Necropsy Methods 0.000 description 12
• 210000004072 lung Anatomy 0.000 description 12
• 108700026244 Open Reading Frames Proteins 0.000 description 11
• 125000003275 alpha amino acid group Chemical group 0.000 description 11
• 239000003242 anti bacterial agent Substances 0.000 description 11
• 238000004113 cell culture Methods 0.000 description 11
• 239000003795 chemical substances by application Substances 0.000 description 11
• 210000003608 fece Anatomy 0.000 description 11
• 210000001035 gastrointestinal tract Anatomy 0.000 description 11
• 230000002829 reductive effect Effects 0.000 description 11
• 239000000523 sample Substances 0.000 description 11
• 238000012546 transfer Methods 0.000 description 11
• 206010012735 Diarrhoea Diseases 0.000 description 10
• 238000002649 immunization Methods 0.000 description 10
• 239000000463 material Substances 0.000 description 10
• 239000013612 plasmid Substances 0.000 description 10
• 210000002966 serum Anatomy 0.000 description 10
• 239000000243 solution Substances 0.000 description 10
• 125000000539 amino acid group Chemical group 0.000 description 9
• 230000000890 antigenic effect Effects 0.000 description 9
• 230000035935 pregnancy Effects 0.000 description 9
• 239000002904 solvent Substances 0.000 description 9
• 239000003381 stabilizer Substances 0.000 description 9
• 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 8
• 238000002965 ELISA Methods 0.000 description 8
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
• 101710197985 Probable protein Rev Proteins 0.000 description 8
• 238000011529 RT qPCR Methods 0.000 description 8
• 150000001413 amino acids Chemical class 0.000 description 8
• 229910002092 carbon dioxide Inorganic materials 0.000 description 8
• 238000009472 formulation Methods 0.000 description 8
• 239000007789 gas Substances 0.000 description 8
• 238000011081 inoculation Methods 0.000 description 8
• 230000035772 mutation Effects 0.000 description 8
• 108091033319 polynucleotide Proteins 0.000 description 8
• 102000040430 polynucleotide Human genes 0.000 description 8
• 239000002157 polynucleotide Substances 0.000 description 8
• 238000006467 substitution reaction Methods 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 7
• 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 7
• 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 7
• 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 7
• 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 7
• 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 7
• 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 7
• 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 7
• 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 7
• 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 7
• 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 7
• 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 7
• 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 7
• 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 7
• 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 7
• 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 7
• 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 7
• 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 7
• 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 7
• 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 7
• 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 7
• 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 7
• 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 7
• 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 7
• 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 7
• 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 7
• 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 7
• 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 7
• 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 7
• 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 7
• 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 7
• 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 7
• 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 7
• 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 7
• 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 7
• 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 7
• 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 7
• 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 7
• 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 7
• 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 7
• 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 7
• 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 7
• 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 7
• 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 7
• 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 7
• 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 7
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
• 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 7
• 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 7
• 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 7
• 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 7
• 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 7
• 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 7
• 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 7
• 238000003556 assay Methods 0.000 description 7
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
• 239000001569 carbon dioxide Substances 0.000 description 7
• 230000002354 daily effect Effects 0.000 description 7
• 238000011161 development Methods 0.000 description 7
• 230000036541 health Effects 0.000 description 7
• 210000001165 lymph node Anatomy 0.000 description 7
• 239000001301 oxygen Substances 0.000 description 7
• 229910052760 oxygen Inorganic materials 0.000 description 7
• 210000002741 palatine tonsil Anatomy 0.000 description 7
• 230000002062 proliferating effect Effects 0.000 description 7
• 229940088710 antibiotic agent Drugs 0.000 description 6
• TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 6
• 238000013461 design Methods 0.000 description 6
• 239000003651 drinking water Substances 0.000 description 6
• 235000020188 drinking water Nutrition 0.000 description 6
• 208000037902 enteropathy Diseases 0.000 description 6
• 239000001963 growth medium Substances 0.000 description 6
• 230000036039 immunity Effects 0.000 description 6
• 239000002054 inoculum Substances 0.000 description 6
• 208000028774 intestinal disease Diseases 0.000 description 6
• 230000003834 intracellular effect Effects 0.000 description 6
• 239000007927 intramuscular injection Substances 0.000 description 6
• 239000008188 pellet Substances 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 230000003584 silencer Effects 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• 241000589902 Leptospira Species 0.000 description 5
• 108010067390 Viral Proteins Proteins 0.000 description 5
• 230000002411 adverse Effects 0.000 description 5
• 238000001514 detection method Methods 0.000 description 5
• 238000010790 dilution Methods 0.000 description 5
• 239000012895 dilution Substances 0.000 description 5
• 238000011156 evaluation Methods 0.000 description 5
• 238000010255 intramuscular injection Methods 0.000 description 5
• 239000007951 isotonicity adjuster Substances 0.000 description 5
• 238000002156 mixing Methods 0.000 description 5
• 235000017709 saponins Nutrition 0.000 description 5
• 238000010186 staining Methods 0.000 description 5
• 230000008719 thickening Effects 0.000 description 5
• 239000013603 viral vector Substances 0.000 description 5
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• 206010015548 Euthanasia Diseases 0.000 description 4
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
• 101000833492 Homo sapiens Jouberin Proteins 0.000 description 4
• 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 4
• 206010022095 Injection Site reaction Diseases 0.000 description 4
• 102100034349 Integrase Human genes 0.000 description 4
• 102100024407 Jouberin Human genes 0.000 description 4
• 206010067482 No adverse event Diseases 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 4
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 4
• 238000004458 analytical method Methods 0.000 description 4
• 238000009395 breeding Methods 0.000 description 4
• 230000001488 breeding effect Effects 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 231100000676 disease causative agent Toxicity 0.000 description 4
• 230000009977 dual effect Effects 0.000 description 4
• 230000007717 exclusion Effects 0.000 description 4
• 239000013604 expression vector Substances 0.000 description 4
• 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 239000004615 ingredient Substances 0.000 description 4
• 230000000968 intestinal effect Effects 0.000 description 4
• 210000003292 kidney cell Anatomy 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 210000005004 lymphoid follicle Anatomy 0.000 description 4
• 239000003755 preservative agent Substances 0.000 description 4
• 230000002265 prevention Effects 0.000 description 4
• 238000012163 sequencing technique Methods 0.000 description 4
• 239000002356 single layer Substances 0.000 description 4
• 238000004114 suspension culture Methods 0.000 description 4
• 230000009885 systemic effect Effects 0.000 description 4
• MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 4
• 239000011534 wash buffer Substances 0.000 description 4
• 230000003442 weekly effect Effects 0.000 description 4
• 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 description 3
• 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 description 3
• 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 description 3
• 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 description 3
• 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 description 3
• 101000765604 Bacillus subtilis (strain 168) FlaA locus 22.9 kDa protein Proteins 0.000 description 3
• 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 description 3
• 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 description 3
• 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 description 3
• 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 description 3
• 241001148534 Brachyspira Species 0.000 description 3
• 101000964402 Caldicellulosiruptor saccharolyticus Uncharacterized protein in xynC 3'region Proteins 0.000 description 3
• 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 description 3
• 108090000565 Capsid Proteins Proteins 0.000 description 3
• 102100023321 Ceruloplasmin Human genes 0.000 description 3
• 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 description 3
• 101000686796 Clostridium perfringens Replication protein Proteins 0.000 description 3
• 108091026890 Coding region Proteins 0.000 description 3
• 238000012286 ELISA Assay Methods 0.000 description 3
• 101710091045 Envelope protein Proteins 0.000 description 3
• 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 description 3
• 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 description 3
• 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 101710126256 Hydrolase in agr operon Proteins 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 description 3
• 101000977779 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized 33.9 kDa protein in PE 3'region Proteins 0.000 description 3
• 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 description 3
• 101000827630 Narcissus mosaic virus Uncharacterized 10 kDa protein Proteins 0.000 description 3
• 101710087110 ORF6 protein Proteins 0.000 description 3
• 101710188315 Protein X Proteins 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 description 3
• 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 description 3
• 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 description 3
• 241000607142 Salmonella Species 0.000 description 3
• 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 3
• 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 description 3
• 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 description 3
• 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 description 3
• 101710172711 Structural protein Proteins 0.000 description 3
• 108010008038 Synthetic Vaccines Proteins 0.000 description 3
• 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 description 3
• 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 3
• 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 description 3
• 230000005856 abnormality Effects 0.000 description 3
• 150000001298 alcohols Chemical class 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 210000001132 alveolar macrophage Anatomy 0.000 description 3
• 239000003429 antifungal agent Substances 0.000 description 3
• 229940121375 antifungal agent Drugs 0.000 description 3
• 239000011324 bead Substances 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 210000000234 capsid Anatomy 0.000 description 3
• 235000011089 carbon dioxide Nutrition 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 238000012512 characterization method Methods 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 238000012761 co-transfection Methods 0.000 description 3
• 238000000576 coating method Methods 0.000 description 3
• 238000012364 cultivation method Methods 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 239000002612 dispersion medium Substances 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 239000012737 fresh medium Substances 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 210000000936 intestine Anatomy 0.000 description 3
• 238000011835 investigation Methods 0.000 description 3
• 238000011031 large-scale manufacturing process Methods 0.000 description 3
• 210000004379 membrane Anatomy 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 238000012544 monitoring process Methods 0.000 description 3
• 229940031348 multivalent vaccine Drugs 0.000 description 3
• 150000007523 nucleic acids Chemical class 0.000 description 3
• 229940124551 recombinant vaccine Drugs 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 238000013341 scale-up Methods 0.000 description 3
• 238000001542 size-exclusion chromatography Methods 0.000 description 3
• 238000001179 sorption measurement Methods 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 241000701161 unidentified adenovirus Species 0.000 description 3
• 235000019786 weight gain Nutrition 0.000 description 3
• 230000004584 weight gain Effects 0.000 description 3
• WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 2
• 206010067484 Adverse reaction Diseases 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 2
• 241001302800 Beak and feather disease virus Species 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
• 241001533384 Circovirus Species 0.000 description 2
• ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical group CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
• 108010041986 DNA Vaccines Proteins 0.000 description 2
• 229940021995 DNA vaccine Drugs 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• 241000283086 Equidae Species 0.000 description 2
• ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
• 241000606790 Haemophilus Species 0.000 description 2
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 2
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 241000710788 Lelystad virus Species 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 108700020497 Nucleopolyhedrovirus polyhedrin Proteins 0.000 description 2
• 101150102680 ORF2b gene Proteins 0.000 description 2
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 238000012300 Sequence Analysis Methods 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• 108010059993 Vancomycin Proteins 0.000 description 2
• 239000000159 acid neutralizing agent Substances 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000006978 adaptation Effects 0.000 description 2
• 230000006838 adverse reaction Effects 0.000 description 2
• 230000000844 anti-bacterial effect Effects 0.000 description 2
• 230000002421 anti-septic effect Effects 0.000 description 2
• 229940064004 antiseptic throat preparations Drugs 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 229940031567 attenuated vaccine Drugs 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 108010006025 bovine growth hormone Proteins 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 210000004081 cilia Anatomy 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 229940028617 conventional vaccine Drugs 0.000 description 2
• 239000012228 culture supernatant Substances 0.000 description 2
• ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 230000000994 depressogenic effect Effects 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 238000002296 dynamic light scattering Methods 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
• 235000021050 feed intake Nutrition 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 238000004108 freeze drying Methods 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 238000003306 harvesting Methods 0.000 description 2
• 230000003862 health status Effects 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 230000002519 immonomodulatory effect Effects 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 230000000415 inactivating effect Effects 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 210000003563 lymphoid tissue Anatomy 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• 238000004264 monolayer culture Methods 0.000 description 2
• 210000004877 mucosa Anatomy 0.000 description 2
• 239000002105 nanoparticle Substances 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 102000039446 nucleic acids Human genes 0.000 description 2
• 108020004707 nucleic acids Proteins 0.000 description 2
• 239000003883 ointment base Substances 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 102000013415 peroxidase activity proteins Human genes 0.000 description 2
• 108040007629 peroxidase activity proteins Proteins 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
• 239000002504 physiological saline solution Substances 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 208000028489 postweaning multisystemic wasting syndrome Diseases 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
• 235000019345 sodium thiosulphate Nutrition 0.000 description 2
• 238000007619 statistical method Methods 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 229940031626 subunit vaccine Drugs 0.000 description 2
• 239000012134 supernatant fraction Substances 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 230000008961 swelling Effects 0.000 description 2
• 229940042585 tocopherol acetate Drugs 0.000 description 2
• 230000014616 translation Effects 0.000 description 2
• 238000005829 trimerization reaction Methods 0.000 description 2
• 229960003165 vancomycin Drugs 0.000 description 2
• MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 210000003501 vero cell Anatomy 0.000 description 2
• 210000002845 virion Anatomy 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• 230000036266 weeks of gestation Effects 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• ICVKYYINQHWDLM-KBEWXLTPSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;2-[(4r,5s,6s,7r,9r,11e,13e,15r,16r)-6-[(2r,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2r,3r,4r,5r,6r)-5-hydroxy-3,4 Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 ICVKYYINQHWDLM-KBEWXLTPSA-N 0.000 description 1
• GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
• RFIMISVNSAUMBU-UHFFFAOYSA-N 2-(hydroxymethyl)-2-(prop-2-enoxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC=C RFIMISVNSAUMBU-UHFFFAOYSA-N 0.000 description 1
• QWVRTSZDKPRPDF-UHFFFAOYSA-N 5-(piperidin-1-ylmethyl)-3-pyridin-3-yl-5,6-dihydro-2h-1,2,4-oxadiazine Chemical compound C1CCCCN1CC(N=1)CONC=1C1=CC=CN=C1 QWVRTSZDKPRPDF-UHFFFAOYSA-N 0.000 description 1
• 101000748061 Acholeplasma phage L2 Uncharacterized 16.1 kDa protein Proteins 0.000 description 1
• 101000977065 Acidithiobacillus ferridurans Uncharacterized 11.6 kDa protein in mobS 3'region Proteins 0.000 description 1
• 101000787133 Acidithiobacillus ferridurans Uncharacterized 12.3 kDa protein in mobL 3'region Proteins 0.000 description 1
• 101000787132 Acidithiobacillus ferridurans Uncharacterized 8.2 kDa protein in mobL 3'region Proteins 0.000 description 1
• 101000827262 Acidithiobacillus ferrooxidans Uncharacterized 18.9 kDa protein in mobE 3'region Proteins 0.000 description 1
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
• 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
• 206010002198 Anaphylactic reaction Diseases 0.000 description 1
• 101000811747 Antithamnion sp. UPF0051 protein in atpA 3'region Proteins 0.000 description 1
• 101100107610 Arabidopsis thaliana ABCF4 gene Proteins 0.000 description 1
• 241001292006 Arteriviridae Species 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 101000977023 Azospirillum brasilense Uncharacterized 17.8 kDa protein in nodG 5'region Proteins 0.000 description 1
• 241000304886 Bacilli Species 0.000 description 1
• 101000827603 Bacillus phage SPP1 Uncharacterized 10.2 kDa protein in GP2-GP6 intergenic region Proteins 0.000 description 1
• 101000827607 Bacillus phage SPP1 Uncharacterized 8.5 kDa protein in GP2-GP6 intergenic region Proteins 0.000 description 1
• 101000961975 Bacillus thuringiensis Uncharacterized 13.4 kDa protein Proteins 0.000 description 1
• 101000961984 Bacillus thuringiensis Uncharacterized 30.3 kDa protein Proteins 0.000 description 1
• 208000031729 Bacteremia Diseases 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 241000255789 Bombyx mori Species 0.000 description 1
• 241000588779 Bordetella bronchiseptica Species 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241001148111 Brucella suis Species 0.000 description 1
• 241000252983 Caecum Species 0.000 description 1
• 101000964407 Caldicellulosiruptor saccharolyticus Uncharacterized 10.7 kDa protein in xynB 3'region Proteins 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 101150044789 Cap gene Proteins 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 241001227713 Chiron Species 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 241000867607 Chlorocebus sabaeus Species 0.000 description 1
• 241001533399 Circoviridae Species 0.000 description 1
• 241000710777 Classical swine fever virus Species 0.000 description 1
• 241000193403 Clostridium Species 0.000 description 1
• 101000947615 Clostridium perfringens Uncharacterized 38.4 kDa protein Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 101000861180 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) Uncharacterized protein H16_B0147 Proteins 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 238000012270 DNA recombination Methods 0.000 description 1
• 206010011906 Death Diseases 0.000 description 1
• 102100036912 Desmin Human genes 0.000 description 1
• 108010044052 Desmin Proteins 0.000 description 1
• 240000006497 Dianthus caryophyllus Species 0.000 description 1
• 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
• 241000271559 Dromaiidae Species 0.000 description 1
• 101000644901 Drosophila melanogaster Putative 115 kDa protein in type-1 retrotransposable element R1DM Proteins 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 241000710945 Eastern equine encephalitis virus Species 0.000 description 1
• 101000747702 Enterobacteria phage N4 Uncharacterized protein Gp2 Proteins 0.000 description 1
• 101000964391 Enterococcus faecalis UPF0145 protein Proteins 0.000 description 1
• 101710121417 Envelope glycoprotein Proteins 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 241000186810 Erysipelothrix rhusiopathiae Species 0.000 description 1
• 101000758599 Escherichia coli Uncharacterized 14.7 kDa protein Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• 241000606807 Glaesserella parasuis Species 0.000 description 1
• 108010015899 Glycopeptides Proteins 0.000 description 1
• 102000002068 Glycopeptides Human genes 0.000 description 1
• 101000748063 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 11.1 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
• 101000768777 Haloferax lucentense (strain DSM 14919 / JCM 9276 / NCIMB 13854 / Aa 2.2) Uncharacterized 50.6 kDa protein in the 5'region of gyrA and gyrB Proteins 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 101000607404 Infectious laryngotracheitis virus (strain Thorne V882) Protein UL24 homolog Proteins 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 101000790840 Klebsiella pneumoniae Uncharacterized 49.5 kDa protein in cps region Proteins 0.000 description 1
• 101000735632 Klebsiella pneumoniae Uncharacterized 8.8 kDa protein in aacA4 3'region Proteins 0.000 description 1
• 238000012773 Laboratory assay Methods 0.000 description 1
• 101000768930 Lactococcus lactis subsp. cremoris Uncharacterized protein in pepC 5'region Proteins 0.000 description 1
• 241000589929 Leptospira interrogans Species 0.000 description 1
• 101000976302 Leptospira interrogans Uncharacterized protein in sph 3'region Proteins 0.000 description 1
• 101000778886 Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) Uncharacterized protein LA_2151 Proteins 0.000 description 1
• 241001550390 Leptospira interrogans serovar Canicola Species 0.000 description 1
• 241000589926 Leptospira interrogans serovar Hardjo Species 0.000 description 1
• 241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 description 1
• 101000977786 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized 9.7 kDa protein in PE 3'region Proteins 0.000 description 1
• 208000008771 Lymphadenopathy Diseases 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 241000282339 Mustela Species 0.000 description 1
• 241000186359 Mycobacterium Species 0.000 description 1
• 241000186367 Mycobacterium avium Species 0.000 description 1
• 241000186364 Mycobacterium intracellulare Species 0.000 description 1
• 241000204031 Mycoplasma Species 0.000 description 1
• 241001138504 Mycoplasma bovis Species 0.000 description 1
• 241001148549 Mycoplasma hyosynoviae Species 0.000 description 1
• 206010028470 Mycoplasma infections Diseases 0.000 description 1
• 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
• 241000204034 Mycoplasmataceae Species 0.000 description 1
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 108091028043 Nucleic acid sequence Proteins 0.000 description 1
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
• 241000606856 Pasteurella multocida Species 0.000 description 1
• 229930195708 Penicillin V Natural products 0.000 description 1
• 241000364057 Peoria Species 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 206010035724 Pneumonia mycoplasmal Diseases 0.000 description 1
• 101710182846 Polyhedrin Proteins 0.000 description 1
• 101000984477 Porcine circovirus 2 Capsid protein Proteins 0.000 description 1
• 241000156302 Porcine hemagglutinating encephalomyelitis virus Species 0.000 description 1
• 241000702619 Porcine parvovirus Species 0.000 description 1
• 241000711493 Porcine respiratory coronavirus Species 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 101710088839 Replication initiation protein Proteins 0.000 description 1
• 101710203837 Replication-associated protein Proteins 0.000 description 1
• 206010038687 Respiratory distress Diseases 0.000 description 1
• 101001121571 Rice tungro bacilliform virus (isolate Philippines) Protein P2 Proteins 0.000 description 1
• 101001113905 Rice tungro bacilliform virus (isolate Philippines) Protein P4 Proteins 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 101100068078 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GCN4 gene Proteins 0.000 description 1
• 241001138501 Salmonella enterica Species 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 101000818100 Spirochaeta aurantia Uncharacterized 12.7 kDa protein in trpE 5'region Proteins 0.000 description 1
• 101000818098 Spirochaeta aurantia Uncharacterized protein in trpE 3'region Proteins 0.000 description 1
• 241000256248 Spodoptera Species 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 101001026590 Streptomyces cinnamonensis Putative polyketide beta-ketoacyl synthase 2 Proteins 0.000 description 1
• 101001037658 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) Glucokinase Proteins 0.000 description 1
• 241000271567 Struthioniformes Species 0.000 description 1
• 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
• 241001485053 Suid betaherpesvirus 2 Species 0.000 description 1
• 241000725681 Swine influenza virus Species 0.000 description 1
• 241000700565 Swinepox virus Species 0.000 description 1
• 101000750896 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized protein Synpcc7942_2318 Proteins 0.000 description 1
• 208000003217 Tetany Diseases 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 241000255993 Trichoplusia ni Species 0.000 description 1
• 208000007885 Vesicular Exanthema of Swine Diseases 0.000 description 1
• 241000711975 Vesicular stomatitis virus Species 0.000 description 1
• 206010058874 Viraemia Diseases 0.000 description 1
• 241000282485 Vulpes vulpes Species 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 101000916321 Xenopus laevis Transposon TX1 uncharacterized 149 kDa protein Proteins 0.000 description 1
• 101000760088 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 20.9 kDa protein Proteins 0.000 description 1
• 229940124532 absorption promoter Drugs 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 208000012927 adermatoglyphia Diseases 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 150000001447 alkali salts Chemical class 0.000 description 1
• 229940086737 allyl sucrose Drugs 0.000 description 1
• 229940087168 alpha tocopherol Drugs 0.000 description 1
• 239000004411 aluminium Substances 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
• 229960004920 amoxicillin trihydrate Drugs 0.000 description 1
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
• 229960003942 amphotericin b Drugs 0.000 description 1
• 238000013103 analytical ultracentrifugation Methods 0.000 description 1
• 230000036783 anaphylactic response Effects 0.000 description 1
• 208000003455 anaphylaxis Diseases 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 238000011203 antimicrobial therapy Methods 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 238000000149 argon plasma sintering Methods 0.000 description 1
• 230000000680 avirulence Effects 0.000 description 1
• 229960004099 azithromycin Drugs 0.000 description 1
• MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
• 239000002585 base Substances 0.000 description 1
• 238000010009 beating Methods 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 229940031416 bivalent vaccine Drugs 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 210000004534 cecum Anatomy 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 239000013553 cell monolayer Substances 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 238000000546 chi-square test Methods 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 229960002626 clarithromycin Drugs 0.000 description 1
• AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000035071 co-translational protein modification Effects 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 229940001442 combination vaccine Drugs 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 238000011217 control strategy Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 239000002274 desiccant Substances 0.000 description 1
• 210000005045 desmin Anatomy 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• 239000012470 diluted sample Substances 0.000 description 1
• 230000009429 distress Effects 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 210000001842 enterocyte Anatomy 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 229960003276 erythromycin Drugs 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• 230000003203 everyday effect Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 238000013401 experimental design Methods 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 230000001200 fecal consistency Effects 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 238000001506 fluorescence spectroscopy Methods 0.000 description 1
• 229940124307 fluoroquinolone Drugs 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000003304 gavage Methods 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 229960002518 gentamicin Drugs 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 244000144980 herd Species 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 210000003701 histiocyte Anatomy 0.000 description 1
• 238000010562 histological examination Methods 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 230000000951 immunodiffusion Effects 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 229940031551 inactivated vaccine Drugs 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
• 210000004347 intestinal mucosa Anatomy 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 210000001630 jejunum Anatomy 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 208000018555 lymphatic system disease Diseases 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 239000003120 macrolide antibiotic agent Substances 0.000 description 1
• 229940041033 macrolides Drugs 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 230000008774 maternal effect Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 238000001471 micro-filtration Methods 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 229940031346 monovalent vaccine Drugs 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000007481 next generation sequencing Methods 0.000 description 1
• 150000004957 nitroimidazoles Chemical class 0.000 description 1
• 238000010899 nucleation Methods 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 229960005030 other vaccine in atc Drugs 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 229940051027 pasteurella multocida Drugs 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 229940056360 penicillin g Drugs 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000020978 protein processing Effects 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• 238000012207 quantitative assay Methods 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 201000010727 rectal prolapse Diseases 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 101150066583 rep gene Proteins 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000001850 reproductive effect Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 238000007790 scraping Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 238000009987 spinning Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 238000000528 statistical test Methods 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 208000012153 swine disease Diseases 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000010998 test method Methods 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 229940040944 tetracyclines Drugs 0.000 description 1
• 238000011287 therapeutic dose Methods 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 229960000984 tocofersolan Drugs 0.000 description 1
• 238000004627 transmission electron microscopy Methods 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 229960001717 tylosin tartrate Drugs 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000010464 virion assembly Effects 0.000 description 1
• 230000001018 virulence Effects 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 239000002076 α-tocopherol Substances 0.000 description 1
• 235000004835 α-tocopherol Nutrition 0.000 description 1
• 125000001020 α-tocopherol group Chemical group 0.000 description 1
• 150000003952 β-lactams Chemical class 0.000 description 1